Sepsis kills more than 350,000 adults in the United States each year and is the leading cause of in-hospital mortality outside of cardiac ICUs. Every hour antibiotics are delayed increases mortality by approximately 7–8%. For nursing students, sepsis is the highest-yield critical care topic on NCLEX-RN and a daily reality on the med-surg floor, emergency department, and ICU. Early recognition is the single greatest determinant of survival – and that is primarily the nurse’s job.
This reference covers Sepsis-3 definitions, SIRS versus Sepsis-3 comparison, qSOFA and SOFA scoring, the 1-hour SEP-1 bundle, vasopressor selection, source control, glucose and corticosteroid management, nursing priorities, complications, and 6 NCLEX-style practice questions. Use alongside the nursing lab values cheat sheet, ABG interpretation guide, and vital signs reference.
Quick reference: sepsis vs septic shock
| Parameter | Sepsis | Septic shock |
|---|---|---|
| Definition | Life-threatening organ dysfunction from dysregulated host response to infection | Subset of sepsis: circulatory and cellular/metabolic dysfunction |
| Organ dysfunction marker | SOFA score increase ≥2 from baseline | SOFA ≥2 + vasopressor requirement + elevated lactate |
| Lactate threshold | >2 mmol/L suggests hypoperfusion | >2 mmol/L despite adequate fluid resuscitation |
| Hemodynamic requirement | Hypotension may be present but not required | Vasopressors required to maintain MAP ≥65 mmHg |
| Mortality | ~10% overall | >40% – highest with both hemodynamic AND metabolic criteria |
| Bedside screening | qSOFA ≥2: altered mentation + RR ≥22 + SBP ≤100 | qSOFA ≥2 + organ dysfunction evidence |
Sepsis-3 definitions: what changed and why it matters
The 2016 Sepsis-3 consensus (Singer M et al., JAMA 2016) replaced the older SIRS-based definitions with criteria centered on organ dysfunction. This was a fundamental shift: the previous SIRS criteria were too sensitive – they flagged patients with uncomplicated post-operative inflammation or a viral upper respiratory infection. Sepsis-3 moved the focus from “infection plus inflammation” to “infection plus organ dysfunction,” which far better predicts clinical deterioration.
The most important change for NCLEX and clinical practice: “severe sepsis” no longer exists as a distinct category under Sepsis-3. The old three-tier model (sepsis → severe sepsis → septic shock) collapsed to two tiers. What was previously called severe sepsis – sepsis with organ dysfunction – is now simply called sepsis. If you encounter “severe sepsis” on older exams or in clinical documentation, recognize it as the pre-2016 classification.
| Term | Current definition (Sepsis-3) | Criteria | Key notes |
|---|---|---|---|
| Sepsis | Life-threatening organ dysfunction caused by a dysregulated host response to infection | Suspected/confirmed infection + SOFA score increase ≥2 from baseline | Replaces both old "sepsis" and "severe sepsis" |
| Septic shock | Subset of sepsis with circulatory and cellular/metabolic dysfunction | Sepsis + vasopressors to maintain MAP ≥65 mmHg + lactate >2 mmol/L despite adequate fluid resuscitation | Both hemodynamic AND metabolic criteria required; mortality >40% |
| qSOFA (bedside screen) | Rapid risk stratification tool – no labs required | ≥2 of: altered mentation (GCS <15), RR ≥22 breaths/min, SBP ≤100 mmHg | Does not define sepsis – prompts full SOFA assessment and lactate measurement |
| SIRS (historical) | No longer used to define sepsis; may appear in hospital alert systems | ≥2 of: temp >38°C or <36°C, HR >90, RR >20 or PaCO2 <32 mmHg, WBC >12,000 or <4,000 or >10% bands | Too sensitive – triggers in non-infectious conditions; abandoned in Sepsis-3 |
SOFA score components
The Sequential Organ Failure Assessment (SOFA) score quantifies organ dysfunction across six organ systems. Each component is scored 0–4; a total increase of ≥2 from the patient’s baseline indicates sepsis when infection is suspected or confirmed.
The six SOFA components: respiration (PaO2/FiO2 ratio), coagulation (platelet count), liver (bilirubin), cardiovascular (MAP and vasopressor requirements), neurological (Glasgow Coma Scale score), and renal (creatinine or urine output). Full SOFA scoring requires laboratory data – this is why qSOFA exists as a rapid bedside screen that requires zero labs and takes under 60 seconds.
Pathophysiology: from infection to organ failure
Sepsis begins when an infection – bacterial, viral, or fungal – triggers an immune response disproportionate to the threat. The cascade from localized infection to multi-organ dysfunction explains every clinical finding and every bundle intervention.
Inflammatory cascade and endothelial damage
Pathogens trigger release of pro-inflammatory cytokines (TNF-α, IL-1, IL-6) throughout the bloodstream. This systemic inflammatory response damages vascular endothelium, making capillary walls permeable: plasma leaks into interstitial tissue (third-spacing), causing edema and intravascular volume depletion simultaneously. Damaged endothelium activates the coagulation cascade, forming microthrombi in small vessels that obstruct capillary blood flow – this microcirculatory failure is the core mechanism of organ dysfunction.
Vasodilation and the warm-to-cold shock transition
Nitric oxide and vasodilatory mediators cause widespread arterial vasodilation, dropping systemic vascular resistance and blood pressure. The heart initially compensates by increasing cardiac output – the warm shock (hyperdynamic) phase: skin warm and flushed, bounding pulses, low blood pressure but high cardiac output. As myocardial depression develops from direct inflammatory injury, the patient transitions to cold shock (hypodynamic) phase: skin cool, mottled, and clammy; weak pulses; markedly reduced cardiac output. The warm-to-cold transition signals cardiovascular decompensation and dramatically elevated mortality.
Metabolic derangement and lactate
Hypoperfused cells shift from aerobic to anaerobic metabolism, producing lactate. Lactate >2 mmol/L indicates inadequate oxygen delivery; >4 mmol/L predicts substantially higher mortality. Mitochondrial dysfunction compounds this – even cells receiving oxygen may be unable to use it efficiently (cytopathic hypoxia).
Clinical presentation and nursing assessment
Recognizing sepsis early is the nurse’s most important role – by the time septic shock is clinically obvious, mortality has already risen substantially.
Early warning signs
Initial sepsis signs are often nonspecific: tachycardia, tachypnea (RR ≥22), fever OR hypothermia (<36°C), and altered mental status (new confusion, agitation, restlessness). Hypothermia is an ominous sign – it carries worse prognosis than fever and should never be dismissed. Elderly and immunocompromised patients may present afebrile; a “normal” temperature does not rule out sepsis.
Other early findings: warm, flushed skin; bounding pulses; widened pulse pressure; declining urine output; leukocytosis or leukopenia; rising lactate; elevated procalcitonin.
Monitoring targets in active sepsis
| Parameter | Target / threshold | Nursing action if abnormal |
|---|---|---|
| MAP | ≥65 mmHg | Initiate or titrate vasopressors if below target despite fluids; insert arterial line if on vasopressors |
| Urine output | ≥0.5 mL/kg/hr | Escalate if <0.5 mL/kg/hr for 2+ consecutive hours – early sign of AKI |
| Lactate | Reassess at 2–4 hours; target clearance ≥20% in 6 hours | Escalate if lactate not clearing – resuscitation strategy may be insufficient |
| Respiratory rate | RR <22 ideal; ≥22 = qSOFA positive | Increasing FiO2 requirements or new bilateral infiltrates may signal early [ARDS](/nursing-tips/ards-nursing/) |
| Mental status | GCS ≥15 at baseline | GCS <15 = qSOFA criterion; new confusion is an early sepsis sign |
| Blood glucose | 140–180 mg/dL | Sepsis causes insulin resistance; monitor closely; avoid hypoglycemia if insulin infusion running |
| Temperature | Fever OR hypothermia (<36°C) both significant | Hypothermia carries worse prognosis; do not ignore in suspected infection |
The 1-hour bundle (SEP-1)
The Surviving Sepsis Campaign (SSC) 2021 guidelines consolidated the prior 3-hour and 6-hour bundles into a single 1-hour bundle. The message is unambiguous: all five elements begin immediately on sepsis recognition. The clock starts at triage – not at ICU admission, not at physician order.
| Bundle element | Target | Nursing implications |
|---|---|---|
| 1. Measure lactate | Obtain initial lactate; remeasure at 2–4 hours if initial >2 mmol/L | Venous or arterial sample acceptable. Lactate >2 mmol/L = tissue hypoperfusion. Lactate >4 mmol/L = high septic shock risk. Serial clearance (≥20% in 6 hours) is a positive prognostic indicator. |
| 2. Blood cultures × 2 | Two sets (aerobic + anaerobic) from two different sites, BEFORE antibiotics | Draw before the first antibiotic dose – but never delay antibiotics more than 45 minutes for culture collection. Do not draw from existing lines (contamination risk) unless no peripheral access is obtainable. |
| 3. Broad-spectrum antibiotics | Administer within 1 hour of recognition | Empiric coverage typically includes a carbapenem or piperacillin-tazobactam ± vancomycin for MRSA coverage. Verify allergies before administering. De-escalate to targeted therapy once culture sensitivities return (typically 24–72 hours). See the [MRSA nursing reference](/nursing-tips/mrsa-nursing/) for vancomycin trough monitoring, contact precautions, and MRSA-specific nursing interventions. |
| 4. 30 mL/kg crystalloid | Rapid IV bolus for hypotension or lactate ≥4 mmol/L | Balanced crystalloid (lactated Ringer's or Plasma-Lyte) preferred over normal saline for large volumes. For a 70 kg patient this equals 2,100 mL. Use large-bore IV (18 gauge or larger). Reassess perfusion after each bolus; monitor for fluid overload (crackles, rising FiO2). |
| 5. Vasopressors if MAP <65 | Start if MAP remains <65 mmHg during or after fluid resuscitation | Norepinephrine is first-line. Can be initiated through a peripheral IV while central access is obtained – do not delay waiting for a central line. Vasopressin is second-line. Vasopressors may start before the full fluid bolus is complete if hypotension is life-threatening. |
Why blood cultures must come first – but not at the cost of antibiotic delay
Blood cultures drawn after antibiotics are administered lose sensitivity rapidly – organisms are killed within 30–60 minutes of the first dose. The goal is cultures first, antibiotics within 1 hour. However, if IV access is difficult and cultures will require more than 45 minutes, administer antibiotics immediately – the mortality cost of a 1-hour antibiotic delay (~7–8% per hour) exceeds the diagnostic value of pre-antibiotic cultures.
Vasopressors in septic shock
Vasopressors become necessary when MAP remains below 65 mmHg despite fluid resuscitation. They work by restoring vascular tone (increasing SVR) that is lost from the massive vasodilation of the inflammatory cascade. For in-depth vasopressor titration, SOFA scoring, corticosteroid dosing, and end-organ monitoring in the hemodynamic deterioration phase, see the dedicated septic shock nursing reference.
| Agent | Line position | Mechanism | Key nursing considerations |
|---|---|---|---|
| Norepinephrine (Levophed) | First-line | Primarily alpha-1 agonist (vasoconstriction); some beta-1 (modest inotropy). Potent MAP restoration with minimal tachycardia. | Standard of care per SSC 2021. Can run peripherally short-term (up to 12–24 hours in well-functioning large IV). Titrate to MAP ≥65 mmHg. Monitor for digital/peripheral ischemia with prolonged use. |
| Vasopressin (Pitressin) | Second-line (add-on to norepinephrine) | V1 receptor agonist – direct vasoconstriction independent of adrenergic pathway. Fixed dose: 0.03–0.04 units/min. | Does NOT titrate by dose (fixed dose only). Added to norepinephrine when norepinephrine alone is insufficient. Reduces norepinephrine requirements. Monitor for water retention (ADH effect). |
| Phenylephrine (Neo-Synephrine) | Alternative – specific indication only | Pure alpha-1 agonist. Strong vasoconstriction with NO beta-1 activity – does not increase heart rate. | Selected when norepinephrine is causing tachyarrhythmia, or when cardiac output is known to be adequate. Reflex bradycardia possible. Not preferred for most septic shock patients due to potential to reduce cardiac output. |
| Epinephrine | Add-on or alternative when norepinephrine + vasopressin insufficient | Alpha + beta-1 + beta-2 agonist. Increases cardiac output and SVR. Also causes bronchodilation. | Risk of tachyarrhythmia. May raise lactate (beta-2 stimulation increases glycogenolysis) – complicate lactate clearance as a monitoring target. |
| Dopamine | Rarely used; limited indication | Dose-dependent: dopaminergic (low), beta-1 (mid), alpha-1 (high) | More arrhythmogenic than norepinephrine; associated with higher mortality in some septic shock studies. Use only in highly selected bradycardic patients. |
Source control
Source control – eliminating or draining the infection source – should occur within 6–12 hours of identification whenever feasible. Examples include surgical drainage of an abscess, removal of an infected vascular catheter or urinary catheter, debridement of infected tissue, or decompression of biliary obstruction. Bone infections such as osteomyelitis can be a hematogenous source that requires surgical debridement alongside prolonged antibiotic therapy.
Nursing role: assess for and report findings that suggest a removable or drainable source (new wound drainage, abdominal rigidity with peritoneal signs, indwelling device-associated erythema). Central venous catheters are a common, easily addressed source – anticipate line removal orders when CLABSI is suspected.
Adjunctive therapies
Corticosteroids for refractory septic shock
Hydrocortisone 200 mg/day IV (continuous infusion or intermittent dosing) is indicated for refractory septic shock: patients who remain hemodynamically unstable despite adequate fluid resuscitation and vasopressor doses above typical therapeutic ranges. Steroids are not recommended for sepsis without shock, or early in septic shock management before vasopressor escalation. Mechanism: adrenal insufficiency is common in critical illness; corticosteroids restore vascular responsiveness and reduce vasopressor requirements. Monitor blood glucose closely – steroids cause significant hyperglycemia.
Glucose management
Sepsis causes profound insulin resistance. Target blood glucose 140–180 mg/dL per SSC 2021 guidelines. Tight glucose control (target <110 mg/dL) increases hypoglycemia risk in critically ill patients without mortality benefit. Monitor hourly or per protocol when insulin infusion is running. Hypoglycemia in a septic patient can be fatal – never stop monitoring because the glucose “looked fine” an hour ago.
DVT prophylaxis
Septic patients are hypercoagulable from the inflammatory state and often immobile. Administer low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) unless contraindicated by active bleeding, platelet count <50,000, or procedural timing. Mechanical prophylaxis (sequential compression devices) for those who cannot receive pharmacological prophylaxis. See DVT nursing reference for full prophylaxis protocols.
Stress ulcer prophylaxis
Administer proton pump inhibitor (PPI) or H2 blocker for patients on mechanical ventilation or with coagulopathy. Stress ulcers develop within 24–48 hours of critical illness from mucosal ischemia – septic patients with compromised mesenteric perfusion are at elevated risk.
Complications of sepsis
| Complication | Mechanism in sepsis | Key signs | Nursing priorities |
|---|---|---|---|
| ARDS | Inflammatory mediators damage alveolar-capillary membrane → protein-rich fluid in alveoli → refractory hypoxemia | Bilateral infiltrates on CXR, PaO2/FiO2 <300, hypoxemia unresponsive to O2 alone | Anticipate intubation; lung-protective ventilation (6 mL/kg IBW, PEEP); prone positioning if P/F <150. See [ARDS nursing](/nursing-tips/ards-nursing/). |
| AKI | Renal hypoperfusion (low MAP) + microvascular thrombosis + direct tubular toxicity | Rising creatinine, urine output <0.5 mL/kg/hr, hyperkalemia, metabolic acidosis | Hourly urine output; strict I&O; monitor potassium; adjust renally-cleared medications; prepare for CRRT. See [AKI nursing](/nursing-tips/aki-nursing/). |
| DIC | Systemic coagulation activation → microthrombi depleting clotting factors + platelets simultaneously | Thrombocytopenia, elevated PT/INR, elevated D-dimer, decreased fibrinogen, bleeding from IV sites | Avoid IM injections; monitor for overt bleeding; administer blood products as ordered; no aspirin/NSAIDs; frequent coagulation labs. |
| MODS | Final pathway when sepsis overwhelms compensatory mechanisms – failure of ≥2 organ systems | Simultaneous dysfunction: lung (ARDS) + kidney (AKI) + liver (rising LFTs) + coagulation (DIC) + brain (encephalopathy) | Monitor all organ systems simultaneously; aggressive supportive care; early goals-of-care discussions with family; escalate immediately to intensivist. |
Priority nursing interventions summary
First 15 minutes
- Establish two large-bore peripheral IVs (18 gauge or larger). Draw blood cultures from the first IV stick before connecting fluids.
- Begin 30 mL/kg crystalloid bolus for hypotension or lactate ≥4 mmol/L.
- Administer broad-spectrum antibiotics within 1 hour. Confirm allergies; hang the first dose before initiating central line placement.
- Draw labs: lactate, CBC, CMP, coagulation panel (PT/INR, aPTT, fibrinogen), procalcitonin, ABG if respiratory distress present.
- Insert Foley catheter for accurate hourly urine output measurement.
First 6 hours
- Hemodynamic reassessment every 15–30 minutes during active resuscitation (MAP, HR, urine output, mental status).
- Repeat lactate at 2–4 hours; escalate if clearance <20%.
- Titrate vasopressors to MAP ≥65 mmHg; document dose changes and hemodynamic response.
- Assess for infection source amenable to control – report to provider within 6 hours.
- Transition from liberal to conservative fluid strategy once initial resuscitation targets are met. Ongoing positive fluid balance increases ARDS risk.
Beyond 6 hours
- De-escalate antibiotics once culture sensitivities return (24–72 hours) – report positive results promptly.
- Target blood glucose 140–180 mg/dL; monitor closely with insulin infusions.
- DVT and stress ulcer prophylaxis.
- Skin assessment and repositioning every 2 hours – vasopressor-induced vasoconstriction creates extreme pressure injury risk.
- Serial lactate until normalization (<2 mmol/L).
NCLEX-style practice questions
Question 1. A nurse is caring for a 68-year-old patient with suspected sepsis. Which action should the nurse take FIRST before initiating IV antibiotics?
A) Insert a Foley catheter to monitor urine output B) Obtain blood cultures from two separate sites C) Draw a complete metabolic panel and CBC D) Administer 30 mL/kg IV crystalloid bolus
Answer: B. Blood cultures must be obtained BEFORE antibiotics to maximize culture sensitivity. Antibiotics begin killing organisms within 30–60 minutes, reducing yield. However, cultures should not delay antibiotic administration by more than 45 minutes.
Question 2. The nurse is assessing a patient with a suspected infection. The patient has a respiratory rate of 23 breaths/min, blood pressure of 94/60 mmHg, and is confused. Which interpretation is most accurate?
A) The patient meets SIRS criteria for sepsis B) The patient has a positive qSOFA screen – further evaluation for sepsis is indicated C) The patient is in septic shock and vasopressors should be started immediately D) The patient’s vital signs are within acceptable limits for an elderly patient
Answer: B. The patient has all three qSOFA criteria (altered mentation, RR ≥22, SBP ≤100 mmHg). qSOFA is a bedside screening tool – a positive score prompts further evaluation including lactate measurement and full SOFA scoring; it does not by itself diagnose sepsis or septic shock. SIRS criteria (option A) are no longer used to define sepsis under Sepsis-3. Vasopressors (option C) are not indicated based on screening alone.
Question 3. A patient with septic shock is receiving IV fluids and norepinephrine. The MAP is 62 mmHg. Which vasopressor is most appropriate to add as the second-line agent?
A) Dopamine B) Phenylephrine C) Vasopressin D) Epinephrine
Answer: C. Vasopressin 0.03–0.04 units/min is the recommended second-line vasopressor per Surviving Sepsis Campaign 2021 guidelines when norepinephrine alone is insufficient to maintain MAP ≥65 mmHg. Dopamine (A) is associated with more arrhythmias and is generally avoided in septic shock. Phenylephrine (B) is a secondary option mainly when tachyarrhythmia complicates norepinephrine use. Epinephrine (D) is a third-line option.
Question 4. A patient with sepsis has a lactate level of 5.2 mmol/L. Based on this finding, which intervention is the highest priority?
A) Administer a 30 mL/kg crystalloid bolus rapidly B) Obtain a 12-lead EKG C) Initiate oral rehydration therapy D) Place the patient in Trendelenburg position
Answer: A. A lactate >4 mmol/L indicates severe tissue hypoperfusion and is one of the triggers for the 1-hour bundle crystalloid bolus (30 mL/kg IV). This is the highest-priority intervention to restore perfusion. An EKG (B) is not the priority. Oral fluids (C) are inappropriate in a critically ill septic patient. Trendelenburg positioning (D) is not recommended and can worsen respiratory status.
Question 5. The nurse is reviewing laboratory results for a patient with sepsis. Which finding best indicates the patient’s condition is improving with treatment?
A) White blood cell count increased from 14,000 to 18,000/μL B) Serum lactate decreased from 4.8 mmol/L to 3.5 mmol/L over 2 hours C) Urine output is 0.3 mL/kg/hr over the past 3 hours D) Blood pressure improved from 84/50 to 90/58 mmHg
Answer: B. Serial lactate clearance is the key marker of improving tissue perfusion in sepsis. A ≥20% decrease in 6 hours is a positive prognostic indicator. The lactate decline here exceeds 20% (from 4.8 to 3.5 mmol/L = 27% decrease), indicating improved cellular oxygen delivery. Rising WBCs (A) reflect ongoing immune response, not improvement. Urine output 0.3 mL/kg/hr (C) is below the target of ≥0.5 mL/kg/hr, indicating inadequate renal perfusion. A MAP of 90/58 = ~69 mmHg meets the MAP ≥65 goal but lactate clearance is the stronger indicator of organ-level response.
Question 6. A nurse is caring for a patient in septic shock who remains hemodynamically unstable after appropriate fluid resuscitation and escalating vasopressor doses. Which adjunctive therapy should the nurse anticipate?
A) High-dose methylprednisolone (Solu-Medrol) 1 g IV B) Hydrocortisone 200 mg/day IV infusion C) Fludrocortisone 100 mcg orally twice daily D) Dexamethasone 10 mg IV push
Answer: B. Hydrocortisone 200 mg/day IV (as continuous infusion or intermittent dosing) is the SSC 2021-recommended corticosteroid for refractory septic shock – patients who fail to stabilize despite adequate fluids and escalating vasopressors. High-dose methylprednisolone (A) is not indicated for sepsis. Fludrocortisone (C) was used in older protocols but is no longer routinely recommended. Dexamethasone (D) has no established role in septic shock management.
NANDA-I nursing care plans for sepsis
The following care plans address the five most clinically significant nursing diagnoses in sepsis. Each is grounded in Surviving Sepsis Campaign (SSC) 2021 guidelines and current NCLEX standards. Every intervention and rationale is sepsis-specific – generic language has been avoided deliberately.
1. Risk for ineffective tissue perfusion
NANDA-I label: Risk for ineffective tissue perfusion (Domain 4: Activity/rest, Class 4: Cardiovascular/pulmonary responses)
Related factors (sepsis-specific):
- Sepsis-induced systemic vasodilation reducing SVR and MAP below 65 mmHg
- Microvascular thrombosis from coagulation cascade activation
- Cytokine-mediated myocardial depression reducing cardiac output
- Anaerobic metabolism with lactate >2 mmol/L indicating cellular hypoperfusion
- Third-spacing of intravascular volume from increased capillary permeability
Risk factors:
- Lactate >2 mmol/L (or >4 mmol/L in septic shock)
- MAP <65 mmHg
- SOFA score increase ≥2 from baseline
- Mottled or cyanotic peripheries; capillary refill >3 seconds
- Urine output <0.5 mL/kg/hr
Short-term goal: Patient will maintain MAP ≥65 mmHg and urine output ≥0.5 mL/kg/hr within 3 hours of initiating the SSC 1-hour bundle.
Long-term goal: Patient will demonstrate lactate clearance ≥20% within 6 hours and will remain hemodynamically stable without escalating vasopressor support within 24 hours.
Nursing interventions:
-
Initiate continuous hemodynamic monitoring (arterial line once vasopressors are running; continuous SpO2, HR, and MAP). Obtain baseline SOFA components: PaO2/FiO2, GCS, bilirubin, MAP/vasopressor requirement, creatinine, and platelet count. Rationale: SOFA score quantifies organ dysfunction across six systems; a rise ≥2 from baseline confirms sepsis. Continuous arterial monitoring provides beat-to-beat MAP data essential for vasopressor titration.
-
Administer 30 mL/kg IV crystalloid bolus (balanced crystalloid preferred – lactated Ringer’s or Plasma-Lyte) within 3 hours of sepsis recognition. For a 70 kg patient, this equals 2,100 mL. Use 18-gauge or larger IV; pressure-bag if needed. Rationale: SSC 2021 mandates 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L. Balanced crystalloids reduce hyperchloremic acidosis risk associated with large-volume normal saline.
-
Perform passive leg raise (PLR) assessment before additional fluid boluses once initial resuscitation is complete. Lift the legs to 45 degrees for 1 minute; measure MAP and stroke volume response if arterial line or cardiac monitor is available. Rationale: PLR is a dynamic test of fluid responsiveness. A ≥10% increase in MAP or cardiac output indicates the patient is preload-responsive and will likely benefit from further fluid. Absence of response signals risk of fluid overload.
-
Initiate norepinephrine if MAP remains <65 mmHg during or after the fluid bolus. Peripheral administration is acceptable for up to 12–24 hours in a functioning large-bore IV while central access is established. Titrate to MAP ≥65 mmHg per SSC 2021 guidelines. Rationale: Norepinephrine is the first-line vasopressor in septic shock. Its predominant alpha-1 agonism restores SVR with minimal tachycardia. Early initiation prevents prolonged hypoperfusion.
-
Assess capillary refill, skin temperature, and mottling score every 30–60 minutes. Document findings using a standardized mottling score (0–5). Rationale: Peripheral perfusion markers reflect microcirculatory status independent of MAP. Persistent mottling despite MAP ≥65 mmHg may indicate ongoing microvascular failure and warrant reassessment of resuscitation strategy.
-
Monitor and trend serum lactate every 2 hours from the initial measurement. Target lactate clearance ≥20% within 6 hours. Escalate to provider if lactate is not clearing. Rationale: Serial lactate clearance is the SSC 2021-endorsed measure of improving tissue oxygenation. Failure to clear lactate at 6 hours is an independent predictor of mortality.
-
Reassess fluid balance status continuously – transition from liberal to conservative fluid strategy once initial resuscitation targets are met. Monitor for fluid overload signs: new crackles, increasing FiO2 requirement, worsening oxygenation, rising CVP. Rationale: Ongoing positive fluid balance beyond initial resuscitation increases ARDS risk and worsens outcomes in sepsis. The SSC 2021 guidelines support moving to a conservative strategy once hemodynamic stability is achieved.
-
Insert urinary catheter for strict hourly urine output measurement. Target ≥0.5 mL/kg/hr. Escalate urine output <0.5 mL/kg/hr for two or more consecutive hours. Rationale: Urine output is an indirect but sensitive bedside measure of renal perfusion. Oliguria in the context of sepsis indicates inadequate MAP or developing AKI and warrants immediate reassessment of resuscitation goals.
2. Impaired gas exchange
NANDA-I label: Impaired gas exchange (Domain 3: Elimination and exchange, Class 4: Respiratory function)
Related factors (sepsis-specific):
- Sepsis-related acute lung injury (ALI) from cytokine-mediated alveolar-capillary membrane damage
- Capillary leak causing protein-rich fluid accumulation in alveoli
- Reduced PaO2/FiO2 ratio (SOFA respiratory component) from ventilation-perfusion mismatch
- Microvascular thrombosis in pulmonary vasculature
- Impaired oxygen delivery to mitochondria despite adequate hemoglobin saturation (cytopathic hypoxia)
Defining characteristics:
- SpO2 <94% or PaO2 <80 mmHg on room air
- Tachypnea (RR ≥22) – a qSOFA criterion
- Increased work of breathing: accessory muscle use, nasal flaring
- Abnormal ABG: respiratory alkalosis (early) progressing to mixed metabolic/respiratory acidosis
- PaO2/FiO2 <300 suggesting early ARDS; <200 moderate ARDS; <100 severe ARDS
Short-term goal: Patient will maintain SpO2 ≥94% and RR <22 within 2 hours of initiating supplemental oxygen and respiratory interventions.
Long-term goal: Patient will demonstrate stable oxygenation (SpO2 ≥94% or PaO2 ≥80 mmHg) without escalation to mechanical ventilation within 24 hours, or – if intubated – will demonstrate lung-protective ventilation parameters and trajectory toward weaning readiness.
Nursing interventions:
-
Administer supplemental oxygen to maintain SpO2 ≥94%. Titrate from nasal cannula to high-flow nasal cannula (HFNC) or non-rebreather mask based on response. In septic shock with refractory hypoxemia, anticipate intubation. Rationale: Sepsis-related hypoxemia often progresses rapidly to ARDS. Early oxygen optimization reduces myocardial oxygen demand and prevents hypoxic end-organ injury.
-
Obtain ABG as ordered, particularly in tachypneic patients or those with altered mental status. Document PaO2/FiO2 ratio using PaO2 from ABG and FiO2 from oxygen delivery device. Rationale: PaO2/FiO2 ratio is the SOFA respiratory component and the diagnostic criterion for ARDS. A P/F ratio <300 with bilateral infiltrates and no cardiac cause of pulmonary edema meets ARDS criteria.
-
Position patient in high Fowler’s (30–45 degrees head elevation) unless hemodynamically contraindicated. Coordinate with the care team regarding prone positioning if P/F ratio falls below 150. Rationale: Head-of-bed elevation reduces aspiration risk and improves diaphragmatic excursion. Prone positioning for severe ARDS (P/F <150) improves oxygenation by recruiting dependent lung units.
-
Assess work of breathing continuously – respiratory rate, accessory muscle use, tracheal tug, SpO2 trend, and patient fatigue. Communicate respiratory deterioration to the provider before the patient becomes exhausted. Rationale: Respiratory muscle fatigue in sepsis is rapid. Early recognition of deteriorating gas exchange allows time for a planned, controlled intubation rather than a crash intubation in extremis.
-
Ensure broad-spectrum antibiotics are administered within 1 hour of sepsis recognition – pulmonary sepsis (pneumonia-sourced) is the most common etiology. Rationale: Source treatment is the definitive intervention for sepsis-related lung injury. Early antibiotics reduce ongoing cytokine release and slow progression of alveolar damage.
-
Monitor fluid balance closely during resuscitation. Titrate toward minimum effective fluid volume once initial resuscitation targets are met. Rationale: Excessive fluid administration exacerbates pulmonary edema in the setting of increased capillary permeability. Fluid overload accelerates progression to ARDS.
-
If mechanically ventilated, implement lung-protective ventilation: tidal volume 6 mL/kg ideal body weight, plateau pressure <30 cmH2O, and titrated PEEP. Rationale: Lung-protective ventilation per the ARDSNet protocol reduces ventilator-induced lung injury and mortality in ARDS. Large tidal volumes overdistend injured alveoli and worsen outcomes.
-
Assess and trend neurological status (GCS, orientation) alongside respiratory status. Rationale: In sepsis, worsening gas exchange and rising PaCO2 can cause encephalopathy. Declining GCS in a hypoxic/hypercapnic patient may indicate imminent respiratory failure requiring intubation.
3. Risk for deficient fluid volume / excess fluid volume
NANDA-I label: Risk for deficient fluid volume (Domain 2: Nutrition, Class 5: Hydration) with concurrent risk for excess fluid volume following resuscitation
Related factors (sepsis-specific):
- Increased vascular permeability from endothelial damage causing intravascular volume depletion despite total body fluid excess
- Systemic vasodilation lowering effective circulating volume
- Fever and tachypnea increasing insensible losses
- Third-spacing: plasma shifts to interstitium creating paradoxical hypovolemia and edema simultaneously
- Post-resuscitation: large-volume crystalloid administration creates risk for pulmonary and peripheral edema
Risk factors:
- Hypotension or MAP <65 mmHg
- Tachycardia
- Low urine output (<0.5 mL/kg/hr)
- Elevated hematocrit from hemoconcentration
- After resuscitation: bilateral crackles, worsening SpO2, increasing FiO2 requirement, peripheral edema
Short-term goal: Patient will receive 30 mL/kg IV crystalloid within 3 hours and demonstrate MAP ≥65 mmHg and urine output ≥0.5 mL/kg/hr.
Long-term goal: Patient will maintain euvolemia – no clinical signs of fluid overload and adequate end-organ perfusion markers – within 24 hours of sepsis recognition.
Nursing interventions:
-
Initiate 30 mL/kg IV crystalloid bolus for hypotension (MAP <65 mmHg) or lactate ≥4 mmol/L per SSC 2021 1-hour bundle. Document start and end time; notify provider when bolus is complete for reassessment. Rationale: The 30 mL/kg crystalloid target is evidence-based from the SSC guidelines. Completion timing drives decisions about vasopressor initiation and second-phase resuscitation.
-
Use balanced crystalloids over normal saline for volumes >1–2 L. Lactated Ringer’s or Plasma-Lyte are preferred. Rationale: Large volumes of 0.9% saline cause hyperchloremic metabolic acidosis from chloride load. This can mimic or exacerbate sepsis-related metabolic acidosis and confound lactate interpretation.
-
Perform passive leg raise test before administering additional fluid boluses beyond the initial 30 mL/kg. Rationale: PLR provides dynamic fluid responsiveness data without administering additional fluid. It prevents unnecessary volume in patients who are not preload-dependent.
-
Track strict hourly input and output. Cumulative fluid balance over 24 and 48 hours is a key prognostic variable. Rationale: A positive cumulative fluid balance >10 L at 72 hours is independently associated with increased mortality and prolonged mechanical ventilation in sepsis.
-
Assess for fluid overload every 1–2 hours during active resuscitation: auscultate lung bases, assess jugular venous distension, check peripheral edema, trend SpO2 and FiO2 requirements. Rationale: Sepsis-related capillary leak means fluid administration extravasates rapidly into tissues. Clinical fluid overload can develop within hours of resuscitation initiation.
-
Transition to conservative fluid management once resuscitation targets are met (MAP ≥65, urine output ≥0.5 mL/kg/hr, lactate trending toward normal). Communicate this transition point clearly during handoff. Rationale: Continued liberal fluid administration after initial resuscitation is complete worsens ARDS, AKI, and abdominal compartment syndrome outcomes.
-
Monitor electrolytes, particularly potassium and sodium, with aggressive fluid therapy. Large crystalloid volumes can shift potassium and sodium, particularly in the setting of AKI. Rationale: Resuscitation-associated electrolyte shifts in a septic patient with renal impairment can cause arrhythmias, neuromuscular dysfunction, and complicate weaning from mechanical ventilation.
-
Document daily weights as soon as the patient is stable enough. A weight gain of >1 kg/day suggests significant fluid accumulation. Rationale: Daily weight is the most reliable indicator of overall fluid balance when IV access, drainage, and insensible losses are difficult to quantify precisely.
4. Risk for infection (secondary or nosocomial)
NANDA-I label: Risk for infection (Domain 11: Safety/protection, Class 1: Infection)
Related factors (sepsis-specific):
- Invasive devices required in sepsis management: central venous catheter (CVC), urinary catheter (Foley), arterial line, endotracheal tube if intubated
- Immunosuppression from sepsis-related immune dysregulation and high-dose corticosteroids (if used for refractory shock)
- Disrupted skin barriers from pressure injuries secondary to vasopressor-induced vasoconstriction
- Inadequate source control if the initial infection source (abscess, infected catheter) has not been removed
- Microbiome disruption from broad-spectrum antibiotics increasing risk of Clostridioides difficile and fungal infections
Risk factors:
- Multiple indwelling devices
- Prolonged broad-spectrum antibiotic exposure (>72–96 hours)
- Immunocompromised state (diabetes, malignancy, corticosteroid use)
- Persistent fever or failure to defervesce after 72 hours of antibiotics
- Rising procalcitonin after initial decline
Short-term goal: Patient will have blood cultures drawn before the first antibiotic dose and will receive broad-spectrum antibiotics within 1 hour of sepsis recognition.
Long-term goal: Patient will demonstrate no new healthcare-associated infections (CLABSI, CAUTI, VAP) during hospitalization, and antibiotics will be de-escalated to targeted therapy within 72 hours of positive culture results.
Nursing interventions:
-
Draw two sets of blood cultures (aerobic and anaerobic) from two separate peripheral sites before administering antibiotics. Do not draw from existing IV or central line ports unless no peripheral access is obtainable. Rationale: Pre-antibiotic blood cultures maximize pathogen yield. Organisms are killed within 30–60 minutes of the first antibiotic dose. Two sets from separate sites improve sensitivity and help distinguish true bacteremia from contaminants.
-
Administer broad-spectrum IV antibiotics within 1 hour of septic shock recognition per SSC 2021. Typical empiric regimens include piperacillin-tazobactam or a carbapenem ± vancomycin for MRSA coverage. Confirm allergies before administration. Rationale: Each hour of antibiotic delay in septic shock increases mortality by approximately 7–8%. Empiric broad-spectrum coverage targets the most likely organisms pending culture results.
-
Identify and report any removable infection source within 6–12 hours. Assess for infected IV/central line sites (erythema, purulence, warmth), wound drainage, urinary catheter-associated symptoms, and signs of intra-abdominal pathology. Rationale: Source control – removal or drainage of the infection focus – is a fundamental pillar of sepsis management. An untreated abscess or infected catheter renders antibiotics insufficient regardless of dose or duration.
-
De-escalate antibiotics to targeted therapy within 24–72 hours once culture sensitivities are available. Report positive culture results to the provider promptly; do not wait for morning rounds. Rationale: Prolonged broad-spectrum antibiotic exposure promotes resistance, increases C. difficile risk, and carries greater adverse effect burden. De-escalation is a patient safety intervention, not just stewardship.
-
Apply CLABSI prevention bundle for all central venous catheters: chlorhexidine-impregnated dressing, daily assessment of line necessity, aseptic technique for all access, and document in the care plan. Rationale: CLABSI adds 10–20 additional hospital days and substantially increases mortality in already-compromised septic patients. Bundle compliance reduces CLABSI rates by over 60%.
-
Apply CAUTI prevention bundle for urinary catheters: insert only when indicated (accurate hourly output monitoring in sepsis is a valid indication), use aseptic insertion technique, and reassess catheter necessity daily. Rationale: Urinary tract infection is among the most common sepsis sources. A CAUTI in a recovering septic patient risks recurrent sepsis.
-
Monitor procalcitonin trend every 48 hours. A falling procalcitonin supports antibiotic de-escalation; a rising procalcitonin after initial improvement may indicate new infection or treatment failure. Rationale: Procalcitonin is a bacterial infection biomarker that rises sharply in sepsis. Serial trending guides antibiotic duration and helps identify secondary infections.
-
Perform twice-daily oral care with chlorhexidine for intubated patients. Rationale: Ventilator-associated pneumonia (VAP) is a major infectious complication in intubated septic patients. Oral decontamination with chlorhexidine 0.12% is a core VAP prevention bundle element that reduces oropharyngeal colonization.
5. Deficient knowledge
NANDA-I label: Deficient knowledge (Domain 5: Perception/cognition, Class 4: Cognition)
Related factors (sepsis-specific):
- Unfamiliarity with sepsis as a syndrome (many patients present without knowing they have an infection)
- Limited health literacy regarding early warning signs of sepsis recurrence after hospital discharge
- High anxiety and cognitive impairment during the acute phase limiting learning readiness
- Lack of prior exposure to ICU-level care requirements (vasopressors, central lines, foley catheter)
- Insufficient understanding of care plan compliance: fluid targets, antibiotic schedule adherence, follow-up
Defining characteristics:
- Patient or family unable to articulate what sepsis is or what caused hospitalization
- Patient unable to describe early warning signs of worsening infection
- Family expresses confusion about monitoring devices, alarms, or medication purposes
- Patient discharged without understanding return-to-ED criteria
Short-term goal: Patient and family will be able to state the definition of sepsis and name two early warning signs of infection by the end of the current shift.
Long-term goal: Prior to discharge, patient will accurately describe at least four early warning signs of sepsis recurrence, state the importance of completing prescribed antibiotics, and identify when to seek emergency care.
Nursing interventions:
-
Assess learning readiness before initiating education. Acute sepsis causes encephalopathy in a significant proportion of patients. Do not attempt complex education during hemodynamic instability; focus family education first. Rationale: Cognitive impairment from sepsis encephalopathy, anxiety, and sleep deprivation limits information retention. Premature education is wasted effort and can increase patient distress.
-
Explain sepsis in plain language during a calm moment: “Your body’s immune system had a very strong reaction to your infection. This caused your blood pressure to drop and stressed your organs. The antibiotics and fluids we gave you are treating both the infection and helping your organs recover.” Rationale: Patients who understand their diagnosis demonstrate better adherence to discharge instructions and return-to-ED criteria. Sepsis survivors have high rates of re-hospitalization within 30–90 days.
-
Teach the early warning signs of sepsis using the UK Sepsis Trust “sepsis six” mnemonic or a locally approved tool. Key signs to review: high temperature or feeling cold/shivering, fast heart rate, fast breathing, confusion or disorientation, extreme pain or discomfort, pale or mottled skin. Rationale: Sepsis recurrence risk is elevated for 90+ days after initial hospitalization. Patients who recognize early warning signs present sooner and have better outcomes.
-
Educate on the importance of completing the full antibiotic course after discharge if oral antibiotics are prescribed. Explain why stopping early increases resistance risk and recurrence risk. Rationale: Non-completion of antibiotic courses is a leading cause of sepsis recurrence and antibiotic resistance. Targeted education at discharge significantly improves completion rates.
-
Involve family caregivers in all education sessions. Provide written materials in the patient’s primary language. Use teach-back to confirm understanding. Rationale: Sepsis survivors often have post-intensive care syndrome (PICS) – cognitive, physical, and psychological impairment that persists after discharge. Family involvement is essential for post-discharge safety.
-
Explain each monitoring device and alarm in plain language to reduce anxiety: “This line in your arm is measuring your blood pressure every second so we can adjust your medications immediately.” Alarm fatigue in patients and families contributes to distress and poor cooperation. Rationale: Understanding why monitoring is in place reduces procedural anxiety and increases cooperation with interventions such as arterial line and central line care.
-
Address discharge criteria clearly: teach the patient and family to call 911 or return to the ED immediately for high fever, sudden confusion, inability to stand, rapid breathing, or skin changes (pale, bluish, mottled). Rationale: Thirty-day readmission rates after sepsis hospitalization range from 20–40%. Clear, specific return-to-ED criteria are a patient safety intervention that reduces delayed re-presentation in recurrent sepsis.
-
Document education provided, method used, and teach-back results in the nursing note. If the patient is unable to participate due to encephalopathy, document that family was educated as the proxy. Rationale: Documented education ensures continuity – the next nurse, case manager, and discharging provider all know what the patient and family understand. It also meets Joint Commission patient education standards.
Frequently asked questions
What is the priority nursing intervention for sepsis?
The highest-priority intervention is obtaining blood cultures from two peripheral sites and administering broad-spectrum intravenous antibiotics within 1 hour of sepsis recognition. Every hour of antibiotic delay in septic shock increases mortality by approximately 7–8%. While cultures should be drawn first to maximize yield, antibiotics must not be delayed more than 45 minutes to obtain them. Fluid resuscitation (30 mL/kg crystalloid) and lactate measurement are initiated simultaneously.
What NANDA-I diagnoses are most appropriate for sepsis?
The five NANDA-I diagnoses most applicable to sepsis are: Risk for ineffective tissue perfusion (Domain 4, Class 4), Impaired gas exchange (Domain 3, Class 4), Risk for deficient/excess fluid volume (Domain 2, Class 5), Risk for infection (Domain 11, Class 1), and Deficient knowledge (Domain 5, Class 4). Prioritization depends on the patient’s current clinical state – in the acute phase, perfusion and gas exchange take precedence over knowledge deficits.
What are the Surviving Sepsis Campaign hour-1 bundle elements?
The SSC 2021 hour-1 bundle contains five elements that begin simultaneously upon sepsis recognition: (1) measure lactate and remeasure at 2 hours if initial level exceeds 2 mmol/L; (2) draw blood cultures from two sites before antibiotics; (3) administer broad-spectrum IV antibiotics within 1 hour; (4) give 30 mL/kg IV crystalloid for hypotension or lactate ≥4 mmol/L; and (5) initiate vasopressors (norepinephrine first-line) if MAP remains below 65 mmHg during or after fluid resuscitation.
How does a nurse assess for septic shock?
Septic shock requires three concurrent findings: confirmed or suspected sepsis, vasopressors required to maintain MAP ≥65 mmHg after adequate fluid resuscitation, and lactate >2 mmol/L despite fluid loading. Bedside assessment includes qSOFA screening (altered mental status + RR ≥22 + SBP ≤100), ongoing blood pressure and MAP monitoring, capillary refill, skin mottling, urine output, and serial lactate. A patient who normalizes MAP with fluid resuscitation alone does not meet septic shock criteria.
What is the difference between SIRS, sepsis, and septic shock?
SIRS (systemic inflammatory response syndrome) describes a non-specific inflammatory response that can occur without infection – it is no longer used to define sepsis under the Sepsis-3 framework. Sepsis (Sepsis-3) is life-threatening organ dysfunction caused by a dysregulated host response to infection, defined by a SOFA score increase of ≥2 from baseline. Septic shock is a subset of sepsis with circulatory and cellular/metabolic dysfunction: vasopressors are required to maintain MAP ≥65 mmHg and lactate remains >2 mmol/L despite adequate fluids. Septic shock carries >40% mortality.
When should vasopressors be initiated in sepsis?
Vasopressors are indicated when MAP remains below 65 mmHg during or after the initial 30 mL/kg fluid resuscitation. Norepinephrine (Levophed) is first-line per SSC 2021 guidelines. They may begin through a well-functioning large peripheral IV while central access is established – waiting for a central line when the patient is hemodynamically compromised causes preventable harm. Vasopressin (0.03–0.04 units/min, fixed dose) is added as the second agent when norepinephrine alone is insufficient.
What lab values indicate worsening sepsis?
Key laboratory markers of deteriorating sepsis include: rising lactate (>2 mmol/L, or failure to clear ≥20% in 6 hours); worsening creatinine and oliguria (renal SOFA component); falling platelet count suggesting DIC; rising bilirubin (hepatic component); declining PaO2/FiO2 ratio suggesting lung injury; rising procalcitonin after initial improvement; and new-onset leukopenia (WBC <4,000) in a previously leukocytotic patient. A SOFA score that continues rising despite resuscitation indicates progression toward multi-organ dysfunction syndrome.
What is the role of lactate monitoring in sepsis management?
Lactate is the primary biomarker of tissue hypoperfusion in sepsis. An initial lactate >2 mmol/L triggers remeasurement at 2 hours (SSC 2021 hour-1 bundle). Lactate >4 mmol/L is one of two triggers for the 30 mL/kg fluid bolus. Serial lactate clearance of ≥20% within 6 hours is a positive prognostic indicator and reflects improving cellular oxygen delivery. Epinephrine can artificially elevate lactate via beta-2-mediated glycogenolysis – account for this in patients receiving epinephrine as a vasopressor. Normalized lactate (<2 mmol/L) in the context of hemodynamic stability supports transition from active resuscitation to monitoring.
Related references
- ARDS nursing – most common respiratory complication of sepsis
- AKI nursing – renal complications: creatinine, urine output, CRRT
- Pneumonia nursing – most common infection source for sepsis
- DVT nursing – DVT prophylaxis in hypercoagulable septic patients
- Pulmonary embolism nursing – differential diagnosis and shared hemodynamic monitoring
- Pyelonephritis nursing – UTI/urosepsis as a common sepsis source
- UTI nursing – catheter-associated sepsis and CAUTI
- Stroke nursing – altered mental status: sepsis vs stroke differential
- Heart failure nursing – shared hemodynamic monitoring priorities; sepsis as HF decompensant
- Pleural effusion nursing – parapneumonic effusion in septic patients
- Tuberculosis nursing reference – miliary and disseminated TB as a cause of sepsis syndrome; covers airborne precautions and RIPE therapy
- ABG interpretation – lactic acidosis and respiratory compensation in sepsis
- Nursing lab values cheat sheet – lactate, WBC, coagulation studies, creatinine
- Vital signs by age – normal range context for tachycardia, tachypnea thresholds
- Glasgow Coma Scale – neurological component of SOFA and qSOFA
- SBAR communication – rapid escalation format when sepsis is suspected
- Electrolyte imbalances – AKI-related hyperkalemia, metabolic acidosis management
Sources and references
- Singer M et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. https://jamanetwork.com/
- Evans L et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine. 2021;49(11):e1063–e1143. https://www.sccm.org/
- Surviving Sepsis Campaign. Hour-1 Bundle. Society of Critical Care Medicine. https://www.sccm.org/
- Centers for Disease Control and Prevention. Sepsis: Data and Reports. https://www.cdc.gov/sepsis/
- National Institute of General Medical Sciences. Sepsis. https://www.nigms.nih.gov/
- Rhodes A et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Medicine. 2017;43(3):304–377. https://www.springer.com/
- American College of Critical Care Medicine. Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. https://www.sccm.org/